As Krystal’s Vyjuvek gains momentum, analysts spotlight ‘transition point’ in topical gene therapy launch zbecker Mon, 08/05/2024 – 14:59 More: As Krystal's Vyjuvek gains momentum, analysts spotlight 'transition point' in topical gene therapy launch Source: fierce
read moreEli Lilly’s Mounjaro, Zepbound back in stock after extended shortage, FDA says zbecker Mon, 08/05/2024 – 10:59 More: Eli Lilly's Mounjaro, Zepbound back in stock after extended shortage, FDA says Source: fierce
read moreBristol Myers telegraphs layoffs in New Jersey, trimming 117 jobs in staggered wave of cuts aliu Mon, 08/05/2024 – 10:46 More: Bristol Myers telegraphs layoffs in New Jersey, trimming 117 jobs in staggered wave of cuts Source: fierce
read moreBioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market fkansteiner Mon, 08/05/2024 – 10:32 More: BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market Source: fierce
read moreBayer’s Kerendia passes key test, cutting risk of cardio death and heart failure kdunleavy Mon, 08/05/2024 – 10:27 More: Bayer's Kerendia passes key test, cutting risk of cardio death and heart failure Source: fierce
read more
Head and neck cancer is currently recognised as the sixth most common cancer globally More: New study reveals certain bacteria are toxic for head and neck cancer Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals